In p50−/− mice injected intracranially with syngeneic glioblastoma cells, CD4+ T‐cell depletion completely eliminated slowed tumor growth, whereas CD8+ T‐cell depletion only partially obviated the effect [15, 16]. The gene discussed is CD4; the disease is glioblastoma.